The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 901–1,000 of 1,071
Cummings, B. J., Su, J. H., Geddes, J. W., Van Nostrand, W. E., Wagner, S. L., Cunningham, D. D., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90265-4 · Cited by 120
Alzheimer's Disease and the Amyloid β-Protein
Walsh, D. M., & Teplow, D. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00012-6 · Cited by 136
“Soluble oligomers of b amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.”
BackgroundInfluentialBeta-Secretase: Structure, Function, and Evolution
Venugopal, C., Demos, C., Jagannatha Rao, K., Pappolla, M., & Sambamurti, K. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784936626 · Cited by 120
Chapter 29 Neuropathological changes in Alzheimer disease
Terry, R. D. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61964-0 · Cited by 143
Coria, F., Castaño, E. M., & Frangione, B. (1987) · PubMed Central · Cited by 136
Simons, M., Ikonen, E., Tienari, P. J., Cid‐Arregui, A., Mönning, U., Beyreuther, K., & Dotti, C. G. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410114 · Cited by 94
Self-citationAPP-BP1, a Novel Protein That Binds to the Carboxyl-terminal Region of the Amyloid Precursor Protein
Chow, N., Korenberg, J. R., Chen, X.-N., & Neve, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11339 · Cited by 129
“The human b-amyloid precursor protein (APP)1 gene (Kang et al., 1987; Goldgaber et al., 1987; Tanzi et al., 1987a; Robakis et al., 1987) encodes a set of APPs (695, 714, 751, and 770 amino acids) that are derived from alternatively spliced mRNAs.”
BackgroundAmyloid in the brains of aged squirrel monkeys
Walker, L. C., Masters, C., Beyreuther, K., & Price, D. L. (1990) · Acta Neuropathologica · doi:10.1007/bf00307691 · Cited by 119
“Amyloid deposits in the brain represent accumulations of extracellular fibrils [20, 21] composed primarily of a 42-43 amino acid fragment (///A4) of a larger amyloid precursor protein (APP) [8, 11 , 27, 32, 38, 42, 50].”
BackgroundSelf-citationNeuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 141
“In the absenceof AQP4, APP mousehad decreased in fl ux of CSF tracer, and accumulation of A β and APOE4 proteins in neurons, as well as phagocytic activation of microglia, suggesting the substantial role of AQP4 during disease progression 160 .”
BackgroundInfluentialSolá, S., Castro, R. E., Laires, P. A., Steer, C. J., & Rodrigues, C. M. P. (2003) · Molecular Medicine · doi:10.2119/2003-00042.rodrigues · Cited by 118
“Aβ is a proteolytic fragment of the large amyloid precursor protein ( 2 ) and has been suggested to play a critical role in the pathogenesis of AD. Previous studies have shown that Aβ-induced toxicity involves oxidative stress, inflammation, and perturbation of calcium homeostasis (3).”
BackgroundKoo, E. H., Sisodia, S. S., Cork, L. C., Unterbeck, A., Bayney, R. M., & Price, D. L. (1990) · Neuron · doi:10.1016/0896-6273(90)90446-m · Cited by 134
Self-citationRole of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis
Maulik, M., Westaway, D. A., Jhamandas, J. H., & Kar, S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8337-y · Cited by 129
“coprotein with a long extracellular N-terminal domain and a short cytoplasmic C-terminal tail [118–122].”
BackgroundAlzheimer's disease: β‐Amyloid protein and tau
Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 116
“In 1987, cDNA encoding -amyloid precursor protein (APP) was cloned (Kang et al., 1987).”
BackgroundWallace, W., Ahlers, S. T., Gotlib, J., Bragin, V, Sugar, J., Gluck, R., Shea, P. A., Davis, K. L., & Haroutunian, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8712 · Cited by 118
ISHII, T., KAMETANI, F., HAGA, S., & SATO, M. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01216.x · Cited by 118
Peptides for Therapy and Diagnosis of Alzheimer's Disease
Funke, S. A., & Willbold, D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799277752 · Cited by 130
“According to a previous version of the amyloid cascade hypothesis, fibrillar forms of A , deposited in amyloid plaques, have been thought to be responsible for neuronal dysfunction [7-11].”
BackgroundSynaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
Li, K., Wei, Q., Liu, F., Hu, F., Xie, A., Zhu, L., & Liu, D. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0533-3 · Cited by 142
“Aβ peptides are proteolytic products of the amyloid precursor protein (APP) and are sequentially cleaved by β- and γ-secretases [15].”
BackgroundBush, A. I., Pettingell, W. H., de Paradis, M., Tanzi, R. E., & Wasco, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47062-7 · Cited by 117
Wiltfang, J., Lewczuk, P., Riederer, P., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H., Vanderstichele, H., Iqbal, K., Galasko, D., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029786 · Cited by 117
Biederer, T., Cao, X., Südhof, T. C., & Liu, X. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07340.2002 · Cited by 117
“Amyloid- precursor protein (APP) of Alzheimer’s disease is a ubiquitous type 1 membrane protein (Kang et al., 1987; Kitaguchi et al., 1988; Tanzi et al., 1988).”
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice
Furlan, R. (2003) · Brain · doi:10.1093/brain/awg031 · Cited by 117
Cholesterol-dependent Generation of a Seeding Amyloid β-Protein in Cell Culture
Mizuno, T., Nakata, M., Naiki, H., Michikawa, M., Wang, R., Haass, C., & Yanagisawa, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15110 · Cited by 117
Bressler, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1589 · Cited by 117
“VP16-cDNA fusion proteins were selected by virtue of their ability to interact with the 106 C-terminal amino acid residues of the human βPP protein ( βC), amino acids 590–695, of βPP695, (14).”
Elroy‐Stein, O., & Groner, Y. (1988) · Cell · doi:10.1016/0092-8674(88)90515-6 · Cited by 117
Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116
“The story of modern AD research was initiated in the 1980s by the identification of the amino acid sequence of the amyloid-β peptide (Aβ) (Glenner & Wong 1984, Masters et al. 1985) and the cloning of the amyloid precursor protein (APP) (Kang et al. 1987).”
Migliorini, C., Porciatti, E., Łuczkowski, M., & Valensin, D. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.004 · Cited by 121
Kazim, S. F., & Iqbal, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0119-y · Cited by 115
Synaptic Elimination in Neurological Disorders
Cardozo, P. L., de Lima, I. B. Q., Maciel, E. M. A., Silva, N. C., Dobransky, T., & Ribeiro, F. M. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190603170511 · Cited by 115
Roberts, S. B., Ripellino, J. A., Ingalls, K. M., Robakis, N. K., & Felsenstein, K. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42055-2 · Cited by 116
Interaction Between Amyloid-β (1–42) Peptide and Phospholipid Bilayers: A Molecular Dynamics Study
Davis, C. H., & Berkowitz, M. L. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.09.053 · Cited by 124
“Biophysical Journal 96(3) 785–797 region of the bilayer.”
BackgroundInfluentialBahr, B. A., Hoffman, K. B., Yang, A. J., Hess, U. S., Glabe, C. G., & LYNCH, G. S. (1998) · PubMed · Cited by 116
Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 125
Health effects of aluminum: a critical review with emphasis on aluminum in drinking water
Nieboer, E., Gibson, B. L., Oxman, A. D., & Kramer, J. R. (1995) · Environmental Reviews · doi:10.1139/a95-002 · Cited by 115
Milojevic, J., Esposito, V., Das, R., & Melacini, G. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067367+ · Cited by 117
Transthyretin and Alzheimer's disease: Where in the brain?
Sousa, J. C., Cardoso, I., Marques, F., Saraiva, M. J., & Palha, J. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.015 · Cited by 114
Zaidi, S. H. E., & Malter, J. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17292 · Cited by 115
Alzheimer Disease: from Molecular Biology to Therapy
Giacobini, E. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)85593-x · Cited by 120
Evidence for lysosomal processing of amyloid ?-protein precursor in cultured cells
Cole, G. M., Huynh, T. V., & Saitoh, T. (1989) · Neurochemical Research · doi:10.1007/bf00965926 · Cited by 115
Pluta, R., Furmaga-Jabłońska, W., Maciejewski, R., Ułamek-Kozioł, M., & Jabłoński, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8360-z · Cited by 114
“resembles a signal transduction receptor [37].”
BackgroundAmiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 113
Diaz, J. C., Simakova, O., Jacobson, K. A., Arispe, N., & Pollard, H. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813355106 · Cited by 113
“PC-12 cells were cultured to near confluence and then incubated with fresh medium and 1 M Abeta [1–42] for 3 days.”
BackgroundMethodInfluentialAlternative splicing of mRNA in the molecular pathology of neurodegenerative diseases
Mills, J. D., & Janitz, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.030 · Cited by 135
“APP The human APP gene is localized on chromosome 21q, nd its transcripts are expressed in many tissue types, with he highest levels of expression occurring in the kidney and he brain (Kang et al., 1987).”
BackgroundPhinney, A. L., Calhoun, M. E., Wolfer, D. P., Lipp, H., Zheng, H., & Jucker, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00645-9 · Cited by 134
Funke, S. A., van Groen, T., Kadish, I., Bartnik, D., Nagel-Steger, L., Brener, O., Sehl, T., Batra-Safferling, R., Moriscot, C., Schoehn, G., et al. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100057j · Cited by 114
“Aβ is produced normally and throughout life as a 39-43 residuepeptide fromtheamyloidprecursorprotein (APP) by two distinct proteolytic activities, called β- and γ-secretases (2-4).”
BackgroundMethodBurdick, D., Kosmoski, J., Knauer, M. F., & Glabe, C. G. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01262-0 · Cited by 102
β-Amyloid Modulation of Synaptic Transmission and Plasticity
Venkitaramani, D. V., Chin, J., Netzer, W. J., Gouras, G. K., Lesne, S., Malinow, R., & Lombroso, P. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3478-07.2007 · Cited by 114
“Within a few years, four groups cloned the amyloid precursor protein (APP) gene from which A is processed (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987).”
BackgroundIt all sticks together—the APP-related family of proteins and Alzheimer's disease
Bayer, T. A., Cappai, R., Masters, C. L., Beyreuther, K. T., & Multhaup, G. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000552 · Cited by 122
Self-citationCloning of the cDNA encoding human brain trypsinogen and characterization of its product
Wiegand, U. K., Corbach, S., Minn, A., Jie, K., & Müller‐Hill, B. (1993) · Gene · doi:10.1016/0378-1119(93)90460-k · Cited by 113
Self-citationExamining the zinc binding site of the amyloid‐β peptide
Yang, D., McLaurin, J., Qin, K., Westaway, D., & Fraser, P. E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01767.x · Cited by 113
“: 1 1 416 978 0102, E-mail: ds.yang@utoronto.ca Abbreviations: Ab, amyloid b-peptide; AD, Alzheimer's disease; APP, amyloid precursor protein.”
BackgroundAlzheimer's Disease, β-Amyloid Protein and Zinc
Huang, X., Cuajungco, M. P., Atwood, C., Moir, R. D., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Nutrition · doi:10.1093/jn/130.5.1488s · Cited by 125
Sundelöf, J., Giedraitis, V., Irizarry, M. C., Sundström, J., Ingelsson, E., Rönnemaa, E., Ärnlöv, J., Gunnarsson, M. D., Hyman, B. T., Basun, H., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.57 · Cited by 113
Tickler, A. K., Smith, D. G., Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414178200 · Cited by 113
Self-citationKimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., & Selkoe, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204446200 · Cited by 113
O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
Jacobsen, K. T., & Iverfeldt, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.080 · Cited by 122
Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits.
Cork, L. C., Masters, C. L., Beyreuther, K. T., & Price, D. L. (1990) · Europe PMC (PubMed Central) · Cited by 116
Self-citationAn Atomic Model for the Pleated β-Sheet Structure of Aβ Amyloid Protofilaments
Li, L., Darden, T. A., Bartolotti, L. J., Kominos, D., & Pedersen, L. G. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77442-4 · Cited by 123
“The principal component of the amyloid plaques is a 39–43-amino acid peptide (Ab) derived from a much larger protein called amyloid b-protein precursor (AbPP) (Kang et al., 1987).”
BackgroundCras, P., van Harskamp, F., Hendriks, L., Ceuterick, C., van Duijn, C. M., Stefanko, S. Z., Hofman, A., Kros, J. M., Van Broeckhoven, C., Martin, J. J., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050892 · Cited by 112
Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype.
Yamatsuji, T., Okamoto, T., Takeda, S., Murayama, Y., Tanaka, N., & Nishimoto, I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00382.x · Cited by 113
Maruyama, K., Terakado, K., Usami, M., & Yoshikawa, K. (1990) · Nature · doi:10.1038/347566a0 · Cited by 120
Werner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35236b · Cited by 112
Hansson, S. F., Andréasson, U., Wall, M., Skoog, I., Andreasen, N., Wallin, A., Zetterberg, H., & Blennow, K. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0966 · Cited by 112
Liu, F., Su, Y., Li, B., Zhou, Y., Ryder, J., Gonzalez-DeWhitt, P., May, P. C., & Ni, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00714-2 · Cited by 112
In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues
Kingston, I. B., Castro, M. J. M., & Anderson, S. (1995) · Nature Medicine · doi:10.1038/nm0295-138 · Cited by 121
De Felice, F. G., Houzel, J.-C., Garcia-Abreu, J., Louzada, P. R. F., Afonso, R. C., Meirelles, M. N. L., Lent, R., Neto, V. M., & Ferreira, S. T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0676fje · Cited by 112
“Residues 29-42 comprise a cluster of nonpolar amino acids contained in a transmembrane sequence of the amyloid precursor protein (35).”
BackgroundCerebral amyloidosis, ageing and Alzheimer's disease; A contribution from studies on Down's syndrome
Mann, D. M. A. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90073-0 · Cited by 114
Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines
Lahiri, D. K., Lewis, S., & Farlow, M. R. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370612 · Cited by 111
Astroglia in Alzheimer's disease
Frederickson, R. C. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90036-w · Cited by 120
Transgenic mouse brain histopathology resembles early Alzheimer's disease
Higgins, L. S., Holtzman, D. M., Rabin, J., Mobley, W. C., & Cordell, B. (1994) · Annals of Neurology · doi:10.1002/ana.410350514 · Cited by 112
APP Receptor? To Be or Not To Be
Deyts, C., Thinakaran, G., & Parent, A. T. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.005 · Cited by 112
“The idea that APP may act as a cell surface receptor was proposed several years ago, basedmainly on structural similarities to type I membrane receptors [39].”
BackgroundMental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms
Rachidi, M., & Lopes, C. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.007 · Cited by 135
Schmaier, A. H., Dahl, L. D., Rozemuller, A. J., Roos, R. A., Wagner, S. L., Chung, R., & Van Nostrand, W. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116863 · Cited by 111
Oishi, M., Nairn, A. C., Czernik, A. J., Lim, G. S., Isohara, T., Gandy, S. E., Greengard, P., & Suzuki, T. (1997) · Molecular Medicine · doi:10.1007/bf03401803 · Cited by 93
“tive splicing of a single gene (3-10) in many”
BackgroundInfluentialAlzheimer's disease and soluble Aβ
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90105-8 · Cited by 118
Babiloni, C., Triggiani, A. I., Lizio, R., Cordone, S., Tattoli, G., Bevilacqua, V., Soricelli, A., Ferri, R., Nobili, F., Gesualdo, L., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00047 · Cited by 106
ADDLs and the signaling web that leads to Alzheimer’s disease
Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 122
“This led to discovery of the amyloid precursor protein (APP) gene in 1987 (Kang et al., 1987), and to the demonstration that fibrillar Ab derived from synthetic peptide could be toxic to cultured neurons (Yankner et al.”
BackgroundAmyloid precursor protein and amyloid precursor-like protein 2 in cancer
Pandey, P., Sliker, B., Peters, H. L., Tuli, A., Herskovitz, J., Smits, K., Purohit, A., Singh, R. K., Dong, J., Batra, S. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7103 · Cited by 109
“Each has an extracellular domain, a transmembrane-spanning domain and a ~50 amino acidlong cytoplasmic tail domain (shown for APP and APLP2 in Figure 1A, 1B) [9,10].”
BackgroundBrain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 121
Vinters, H. V., Nishimura, G. S., Secor, D. L., & Pardridge, W. M. (1990) · Europe PMC (PubMed Central) · Cited by 118
Murtomäki, S., Risteli, J., Risteli, L., Koivisto, U. ‐., Johansson, S., & Liesi, P. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320216 · Cited by 110
Altered Calcium Signaling and Neuronal Injury: Stroke and Alzheimer's Disease as Examplesa
MATTSON, M. P., RYDEL, R. E., LIEBERBURG, I., & SMITH‐SWINTOSKY, V. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb18285.x · Cited by 110
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Iqbal, K., Liu, F., & Gong, C.-X. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.002 · Cited by 109
“Plaques are extracellular deposits mainly composed of Aβ1-40 and Aβ1-42 which are the metabolites of amyloid precursor protein (APP) generated by its β- and β-secretase cleavage [12-14].”
BackgroundFatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 139
“The isolation of β-amyloid from the plaques led to the cloning of amyloid precursor protein (APP) (Kang et al., 1987) and the localization of the APP gene to chromosome 21.”
Pluta, R. M., Kida, E., Lossinsky, A. S., Golabek, A. A., Mossakowski, M. J., & Wisniewski, H. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91081-2 · Cited by 114
Tan, L., Schedl, P., Song, H.-J., Garza, D., & Konsolaki, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003966 · Cited by 109
“The first AD-related mutations identified were in the amyloid b precursor protein (APP), a type I integral membrane protein [3–6].”
BackgroundFukumoto, H., Asami-Odaka, A., Suzuki, N., Shimada, H., Ihara, Y., & Iwatsubo, T. (1996) · Europe PMC (PubMed Central) · Cited by 131
Microglia in cerebellar plaques in Alzheimer's disease
Mattiace, L. A., Davies, P., Yen, S. H., & Dickson, D. W. (1990) · Acta Neuropathologica · doi:10.1007/bf00294609 · Cited by 109
“Increased synaptic stripping in the AD cerebellum may lead to increased processing of synaptic proteins, one of which may be the amyloid precursor protein [ 19 , 38].”
BackgroundThe neuropeptide PACAP attenuates β-amyloid (1–42)-induced toxicity in PC12 cells
Onoue, S., Endo, K., Ohshima, K., Yajima, T., & Kashimoto, K. (2002) · Peptides · doi:10.1016/s0196-9781(02)00085-2 · Cited by 113
Backstrom, J. R., Miller, C. A., & Tökés, Z. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09352.x · Cited by 109
Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., & Song, W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12235 · Cited by 108
“APP695 is the major isoform in neuronal cells, whereas APP751 and APP770 are predominantly expressed in other cell types (Kang et al., 1987; Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988).”
BackgroundDelineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108
“Overexpress- ing RAGE-APP double transgenic mice potentiated the neurotoxic effects of Ab resulting in earlier onset of memory defects and synaptic dysfunction [51].”
BackgroundInfluentialYamazaki, T., Koo, E. H., & Selkoe, D. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01004.1997 · Cited by 104
“Ab is derived by proteolytic cleavages from the b-amyloid precursor protein (bPP) (Kang et al., 1987).”
Synaptic Dysfunction in Alzheimer’s Disease
Marcello, E. E., Epis, R., Saraceno, C., & Luca, M. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_25 · Cited by 125
Giannoni, P., Gaven, F., de Bundel, D., Baranger, K., Marchetti-Gauthier, E., Roman, F. S., Valjent, E., Marin, P., Bockaert, J., Rivera, S., et al. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00096 · Cited by 107
Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 117
“Many years after the study by Alzheimer, the structures he studied have been well characterized and are known as neurofibrillary tangles and senile plaques consisting mainly of the beta-amyloid protein (bA protein; Kang et al. 1987; Glenner 1988; Braak and Braak 1991).”
BackgroundRole of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury
Mi, Z., & Graham, S. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101856 · Cited by 121
APP Gene Family Alternative Splicing Generates Functionally Related Isoformsa
SANDBRINK, R., MASTERS, C. L., & BEYREUTHER, K. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34433.x · Cited by 89
Self-citationSáez‐Valero, J., Sberna, G., McLean, C., & Small, D. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721600.x · Cited by 115
“One of the hallmarks of AD pathology is the amyloid plaque, which consists principally of the b-amyloid protein (Ab) (Masters et al., 1985), a 4-kDa polypeptide produced from a larger type I transmembrane glycoprotein, the amyloid protein precursor (Kang et al., 1987).”
BackgroundHerms, J., Schneider, I., Dewachter, I., Caluwaerts, N., Kretzschmar, H., & Van Leuven, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206769200 · Cited by 108
Kawabata, S., Higgins, G. A., & Gordon, J. W. (1991) · Nature · doi:10.1038/354476a0 · Cited by 108
Retracted
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.